Edgewise Therapeutics Inc (EWTX)

Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	14.47%61.94	54.12	55.98	46.86	42.61
Research and Development	11.48%47.55	42.65	43.59	37.48	33.56
Operating Income/Loss	14.47%-61.94	-54.12	-55.98	-46.86	-42.61
	16.96%-57.33	-49.01	-50.22	-40.67	-36.12
Attributable To Parent	16.96%-57.33	-49.01	-50.22	-40.67	-36.12
Basic Average Shares	0.52%107.67	107.12	1.04	105.49	104.94
Diluted Average Shares	0.52%107.67	107.12	1.04	105.49	104.94
Basic Earnings Per Share	15.22%-0.53	-0.46	-0.48	-0.39	-0.34
Diluted Earnings Per Share	15.22%-0.53	-0.46	-0.48	-0.39	-0.34